FDA Expects Guidance On Validating Device Development Tools To Speed Approvals

A new FDA draft guidance establishes a voluntary process to validate publicly available device development tools so companies can routinely apply them to facilitate their path to market.

A draft guidance issued Nov. 13 by FDA seeks to speed up the approval pathway for medical devices by introducing a voluntary process to get development tools validated so that any company that wishes can use them.

The draft defines a medical device development tool (MDDT), as a scientifically validated method that aids in device development and regulatory evaluation. Such tools can include a clinical outcome assessment...

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on Medtech Insight for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required

More from Regulation

More from Policy & Regulation